Caged Luciferase Inhibitor‐Based Bioluminescence Switching Strategy Enables Efficient Detection of Serum APN Activity and the Identification of Its Roles in Metastasis of Non‐Small Cell Lung Cancer.

MLA

Li, Yunzhi, et al. “Caged Luciferase Inhibitor‐Based Bioluminescence Switching Strategy Enables Efficient Detection of Serum APN Activity and the Identification of Its Roles in Metastasis of Non‐Small Cell Lung Cancer.” Chemistry - A European Journal, vol. 29, no. 51, Sept. 2023, pp. 1–14. EBSCOhost, https://doi.org/10.1002/chem.202300655.

APA

Li, Y., Wu, J., Jin, C., Zhang, Y., Wang, J., Wang, X., Li, H., Zhang, X., Liu, T., Zhou, D., Kuang, Y., Wu, W., Wang, Y., Ke, Z., Bu, X., & Yue, X. (2023). Caged Luciferase Inhibitor‐Based Bioluminescence Switching Strategy Enables Efficient Detection of Serum APN Activity and the Identification of Its Roles in Metastasis of Non‐Small Cell Lung Cancer. Chemistry - A European Journal, 29(51), 1–14. https://doi.org/10.1002/chem.202300655

Chicago

Li, Yunzhi, Jiaxin Wu, Chaoying Jin, Yiqiu Zhang, Jiyu Wang, Xuecen Wang, Huixia Li, et al. 2023. “Caged Luciferase Inhibitor‐Based Bioluminescence Switching Strategy Enables Efficient Detection of Serum APN Activity and the Identification of Its Roles in Metastasis of Non‐Small Cell Lung Cancer.” Chemistry - A European Journal 29 (51): 1–14. doi:10.1002/chem.202300655.